Psychopharmacology Online 19 May 2007
Read Full Abstract
Reprint Request E-mail: ddavids2@iupui.edu
________________________________________________________________________
Twelve weeks of naltrexone significantly improves drinking outcomes in alcoholics; however, the clinical benefits of naltrexone decline shortly after treatment is discontinued.
The present study investigated whether extended treatment with naltrexone significantly improved drinking outcomes.
The results of this study suggest that administering naltrexone beyond an initial 12 weeks of treatment may not be beneficial to all patients and should be administered along with close medical monitoring to insure compliance.
The results of this study suggest that administering naltrexone beyond an initial 12 weeks of treatment may not be beneficial to all patients and should be administered along with close medical monitoring to insure compliance.
Read Full Abstract
Reprint Request E-mail: ddavids2@iupui.edu
________________________________________________________________________